Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01871116 · ClinicalTrials.gov registry record · NA

POWER-remote Weight Loss Program in Early Stage Breast Cancer

A NA study of Early Stage Breast Cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Completed
Registry status
NA
Development phase
96
Enrollment target
1
Study location

NCT01871116 is a NA study of Early Stage Breast Cancer that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 96 participants, below the 409-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01871116, a NA study of Early Stage Breast Cancer, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target
1
Study location

Study Summary

This research is being done to assess the effectiveness of a weight loss program in women with early stage breast cancer whose body mass index (BMI) is in the overweight or obese range (\>25). Weight loss is beneficial in improving cardiovascular risk factors and overall health, but may also decrease the chance of breast cancer coming back. A weight loss counseling program was studied in a general population and was found to be effective to help reduce weight over a 2 year period. The main goal of this study is to determine if women with a recent diagnosis of early breast cancer will also lose weight with this program. To better understand the effect that weight loss has on women with breast cancer, we will compare the patterns in blood and breast tissue samples (tissue biopsies will be optional), and questionnaires evaluating different aspects of one's well-being, before and after a dietary intervention or no intervention.

Conditions Studied

Interventions

  • BEHAVIORAL POWER-remote
  • BEHAVIORAL Self-directed

Study Locations (1)

Maryland

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins - Baltimore

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2013-07
Est. Completion 2016-12
Phase NA

What the Registry Record Tells You About NCT01871116

The ClinicalTrials.gov registry entry for NCT01871116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 409-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (77% lower). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Early Stage Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which POWER-remote is the first listed.

NCT01871116 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01871116 about?

NCT01871116 is a clinical study titled "POWER-remote Weight Loss Program in Early Stage Breast Cancer". This research is being done to assess the effectiveness of a weight loss program in women with early stage breast cancer whose body mass index (BMI) is in the overweight or obese range (\>25). Weight loss is beneficial in improving cardiovascular risk factors and overall health, but may also decreas...

What is the current status of trial NCT01871116?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2013-07. Estimated completion is 2016-12.

What conditions does trial NCT01871116 study?

This clinical trial studies the following conditions: Early Stage Breast Cancer.

What interventions are being tested in trial NCT01871116?

The interventions under investigation include: POWER-remote (BEHAVIORAL), Self-directed (BEHAVIORAL).

Who is sponsoring clinical trial NCT01871116?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01871116 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Early Stage Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.